Positive interim results from Phase I/II multiple myeloma cancer vaccine trial

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [41] Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results
    Ailawadhi, Sikander
    Parrondo, Ricardo D.
    Moustafa, Muhamad Alhaj
    LaPlant, Betsy R.
    Alegria, Victoria
    Chapin, Dustin
    Roy, Vivek
    Sher, Taimur
    Paulus, Aneel
    Chanan-Khan, Asher A.
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 695 - 703
  • [42] Interim Results of a Phase 2 Trial of Isatuximab-Lenalidomide for Patients with High-Risk Smoldering Multiple Myeloma
    Thomas, Sheeba
    Manasanch, Elisabet
    Korde, Neha
    Lee, Hans
    Jagannath, Sundar
    Becnel, Melody
    Kaufman, Gregory
    Patel, Krina
    Iyer, Swaminathan
    Mailankody, Sham
    Weber, Donna
    Lutter-Berka, Zuzana
    Carpenter, Shawnee
    Nolasco, David Berrios
    Hildebrandt, Michelle
    Feng, Lei
    Amini, Behrang
    Neelapu, Sattva
    Orlowski, Robert
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S27 - S27
  • [43] Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
    Tim Roehnisch
    Cornelia Then
    Wolfgang Nagel
    Christina Blumenthal
    Todd Braciak
    Mariel Donzeau
    Thomas Böhm
    Michael Flaig
    Carole Bourquin
    Fuat S Oduncu
    Journal of Translational Medicine, 12
  • [44] A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma
    Mikhael, Joseph R.
    Roy, Vivek
    Richardson, Paul G.
    Jakubowiak, Andrzej
    Laumann, Kristina
    LaPlant, Betsy R.
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Fonseca, Rafael
    Leung, Nelson
    Buadi, Francis
    Bergsagel, Leif
    Kyle, Robert
    Witzig, Thomas E.
    Reeder, Craig
    Lust, John A.
    Russell, Stephen
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Dingli, David
    Ansell, Stephen M.
    Dalton, Robert
    Lin, Yi
    Sher, Taimur
    Kapoor, Prashant
    McCurdy, Arleigh
    Chanan-Khan, Asher
    Stewart, A. Keith
    Gertz, Morie A.
    Lacy, Martha Q.
    BLOOD, 2013, 122 (21)
  • [45] A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Lee, Hans C.
    Shah, Jatin J.
    Feng, Lei
    Morphey, Ashley
    Johnson, Ralph J.
    Wesson, Emily T.
    Wang, Michael L.
    Alexanian, Raymond
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Weber, Donna M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : E319 - E322
  • [46] Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
    Roehnisch, Tim
    Then, Cornelia
    Nagel, Wolfgang
    Blumenthal, Christina
    Braciak, Todd
    Donzeau, Mariel
    Boehm, Thomas
    Flaig, Michael
    Bourquin, Carole
    Oduncu, Fuat S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [47] Peregrine's TNT treatment shows positive results in phase I/II trial
    不详
    DRUG NEWS & PERSPECTIVES, 2001, 14 (05) : 295 - 295
  • [48] Positive results for GSK malaria vaccine in Phase III trial
    Riedmann, Eva M.
    HUMAN VACCINES, 2011, 7 (12): : 1246 - 1246
  • [49] A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results.
    Lunning, Matthew Alexander
    Ruan, Jia
    Nair, Sumithra
    Boruchov, Adam M.
    Byrne, Regina
    Gerecitano, John F.
    Hamlin, Paul A.
    Inserra, Beth
    Leonard, John
    Lynch, Peggy
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Moskowitz, Craig
    Myskowski, Patricia L.
    Nolan, Patrick
    Palomba, Maria Lia
    Quefeld, Christiane
    Straus, David J.
    Zelenetz, Andrew David
    Horwitz, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Spinal intraarterial chemotherapy: interim results of a Phase I clinical trial
    Patsalides, Athos
    Yamada, Yoshiya
    Bilsky, Mark
    Lis, Eric
    Laufer, Ilya
    Gobin, Yves Pierre
    JOURNAL OF NEUROSURGERY-SPINE, 2016, 24 (02) : 217 - 222
12345